Bengt Samuelsson has served as a director on the boards of Pharmacia AB, NicOx SA and Schering AG and is an advisor to the venture capital fund HealthCap.
The company Pyrosequencing AB in Uppsala, Sweden was founded with venture capital provided by HealthCap in order to commercialize machinery and reagents for sequencing short stretches of DNA using the pyrosequencing technique.
(OTC Pink:TNGN), is an American development-stage regenerative medicine company founded in 2003 with financing from J&J Development Corporation, HealthCap and Oak Investment Partners, which is headquartered in Winston-Salem, North Carolina.